Skip to content
HowShorted

REGENXBIO Inc. short interest in 2019

In 2019, REGENXBIO Inc.'s disclosed short interest ran from 6.98% of shares outstanding on 15 Jan 2019 to 10.91% on 31 Dec 2019, a change of +3.93 percentage points. The year's high was 12.47% on 31 Oct 2019 and its low 6.98% on 15 Jan 2019, averaging 10.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.10 days on 31 Dec 2019. Full history: REGENXBIO Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REGENXBIO Inc. in 2019

2019 in figures

Start of year
6.98% (15 Jan 2019)
End of year
10.91% (31 Dec 2019)
Change
+3.93 pp
High
12.47% (31 Oct 2019)
Low
6.98% (15 Jan 2019)
Average
10.00%
Highest days to cover
10.10 (31 Dec 2019)
SEC filings marked
9

Every report in 2019

REGENXBIO Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20196.98%5.07results (8-K)
31 Jan 20197.01%5.99
15 Feb 20197.48%6.34
28 Feb 20199.07%4.7910-K filed, results (8-K)
15 Mar 20199.93%4.83
29 Mar 20199.83%6.60
15 Apr 20198.61%6.90
30 Apr 20199.06%5.54
15 May 201910.36%6.9610-Q filed, results (8-K)
31 May 201911.13%5.15
14 Jun 20198.98%7.28
28 Jun 201910.20%6.02
15 Jul 201910.62%8.33
31 Jul 201910.56%7.55
15 Aug 201910.44%5.6410-Q filed, results (8-K)
30 Aug 20198.75%7.05
13 Sep 20199.82%4.87
30 Sep 201911.32%7.47
15 Oct 201912.29%7.34
31 Oct 201912.47%9.01
15 Nov 201911.62%8.7110-Q filed, results (8-K)
29 Nov 201911.33%8.91
13 Dec 201911.21%7.74
31 Dec 201910.91%10.10

See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.